Heidi has acquired UK-based clinical AI firm AutoMedica as it bids to evolve from an AI scribe to an AI care partner.
The firm said its acquisition will seek to bring clinical AI expertise and NHS regulatory experience into its global platform.
It is launching Heidi Comms which allows healthcare teams to coordinate patient communications across calls, bookings, reminders and follow-ups.
Heidi Evidence is a clinical-grade research tool, integrated directly into the Heidi platform, which will launch in UK private clinical settings ahead of rollout across the NHS.
It has been built in partnership with EMGuidance and NICE Guidelines, among others, to ensure guidance reflects regional standards and formularies, the firm said.
In order to ensure ad-free integrity, it also features a permanent commitment to non-commercial, auditable data, ensuring clinical decisions are never influenced by advertising.
Heidi added the launches were a step into becoming an AI care partner, bridging the gap between clinical documentation and real-time clinical reasoning.
It said this would accelerate its technical and regulatory capabilities and access to the Medicines and Healthcare products Regulatory Agency (MHRA) sandbox for healthcare AI.
Integrity of evidence
Dr Thomas Kelly, co-founder and CEO of Heidi, said: “We believe that for AI to be a true care partner, the integrity of its evidence must be non-negotiable.
“As we see more general-purpose AI platforms like OpenAI move toward ad-supported models, consumers are rightly concerned about hidden influence.
“In a healthcare setting, that concern becomes paramount. Bringing transparent, clinical-grade insights into the room makes it easier to deliver quality care, but that information must be free from the ambiguity of commercial influence.
“By committing to Evidence being ad-free and independent, we ensure clinicians can stay present with their patients, knowing their decision-making is built on pure clinical rigor, not a business model.”
Dr Ben Turner, co-founder of AutoMedica, said: “From the outset we have believed that clinical AI must be built within real healthcare structures, not bolted on around the edges.
“Working through the NHS AI Airlock has shown that when regulators, clinicians and technologists come together, it is possible to build AI that is both ambitious and safe by design.
“Joining Heidi means we can take what we have learned and apply it at a far greater scale, within a platform that shares our focus on evidence, safety and the realities of day-to-day clinical practice.”